MDP.TO · Medexus Pharmaceuticals Inc.
Canada · RS rating 69 · As of 2026-10-14
| Price | 4.83 CAD |
|---|---|
| 1-day change | +0.2% |
| RS rating (overall / 1M / 3M / 12M) | 69 / 41 / 34 / 89 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 35 / 38 / 18 |
| Industry group (rank) | Medical-Generic Drugs (45) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +15.9% |
| Distance from 52-week high | +11.4% |
| Market cap (USD) | $109.3M |